Schweinfurthins and Uses Thereof
Disclosed is a method for preventing or treating an undesirable condition in a subject carrying cells homozygous null for the neurofibromatosis type 1 gene or subjects that are haploinsufficient for the neurofibromatosis type 1 gene, the method comprising administering to a subject in need thereof an effective amount of a schweinfurthin or schweinfurthin analog or derivative, or a pharmaceutically acceptable salt, prodrug, hydrate, or solvate thereof. Also disclosed is a new schweinfurthin compound of the formula.
Attached files:Patents:WO 2,010,127,235
Inventor(s):
REILLY KARLYNE [US]; TURBYVILLE THOMAS [US]; BEUTLER JOHN A [US]; WIEMER DAVID [US]
Type of Offer:
Licensing
« More Biotech Patents